Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions



Rating:

Share or cite this content

Citations should be made in the following way:
C. O'Sullivan (Melbourne, Australia), K. Nilsen (Melbourne, Australia), K. Prisk (San Diego, United States of America), A. Voskrebenzev (Hannover, Germany), J. Vogel-Claussen (Hannover, Germany), B. Thompson (Melbourne, Australia). Late Breaking Abstract - Spatial response to small and large particle bronchodilator in subjects with asthma. 422

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from  ATLANTIS Study Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Late Breaking Abstract - Expiratory variability index (EVI) in young children during asthma exacerbation Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019 Late Breaking Abstract - Explore the effective dose of bronchodilator nebulization via high flow nasal cannula in adult COPD and asthma patients Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections Year: 2021 Late Breaking Abstract - Effect of inhaled corticosteroids on exacerbation of asthma–COPD overlap according to different diagnostic criteria Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Late Breaking Abstract - Performance of artificial intelligence in determining the intensity of abnormal breath sounds in asthma patients. Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Late Breaking Abstract: Fluticasone/salmeterol combination confers significant benefits in smoking asthmatics Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Late Breaking Abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations Source: International Congress 2019 – Airway physiology Year: 2019 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract: Tiotropium improves lung function in patients with severe uncontrolled asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Late Breaking Abstract - Dietary patterns and lung function in a case-control study of asthma in Italian adults. Source: International Congress 2019 – More and more COPD Year: 2019